{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:02:01Z","timestamp":1794452521113,"version":"4.9.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["IND2020\/BIO-17523"],"award-info":[{"award-number":["IND2020\/BIO-17523"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP18\/00106"],"award-info":[{"award-number":["CP18\/00106"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00738"],"award-info":[{"award-number":["PI22\/00738"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00789"],"award-info":[{"award-number":["PI22\/00789"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00184"],"award-info":[{"award-number":["PI19\/00184"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["DTS20\/00109"],"award-info":[{"award-number":["DTS20\/00109"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["AES20-ISCIII"],"award-info":[{"award-number":["AES20-ISCIII"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00639"],"award-info":[{"award-number":["PI20\/00639"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["IDI\/2021\/000032"],"award-info":[{"award-number":["IDI\/2021\/000032"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005884","name":"Centro Nacional de Investigaciones Cardiovasculares","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015883","name":"Sociedad Espa\u00f1ola de Nefrolog\u00eda","doi-asserted-by":"publisher","award":["SEN 2022"],"award-info":[{"award-number":["SEN 2022"]}],"id":[{"id":"10.13039\/100015883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116492","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T09:56:00Z","timestamp":1711446960000},"page":"116492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["BET inhibitor nanotherapy halts kidney damage and reduces chronic kidney disease progression after ischemia-reperfusion injury"],"prefix":"10.1016","volume":"174","author":[{"given":"Maria Laura","family":"Saiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lozano-Chamizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida Bernardo","family":"Florez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Marciello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Diaz-Bulnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Corte-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian Ruiz","family":"Bernet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul R.","family":"Rodrigues-Diez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Martin-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Rodriguez-Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3141-6493","authenticated-orcid":false,"given":"Ivan","family":"Fernandez-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon M.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Diaz-Corte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3431-4206","authenticated-orcid":false,"given":"Beatriz","family":"Suarez-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8142-4566","authenticated-orcid":false,"given":"Marco","family":"Filice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Lopez-Larrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2024.116492_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.kint.2021.06.028","article-title":"Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: improving global outcomes (KDIGO) consensus conference","volume":"100","author":"Lameire","year":"2021","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.biopha.2024.116492_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12010375","article-title":"Acute kidney injury: medical causes and pathogenesis","volume":"12","author":"Turgut","year":"2023","journal-title":"J. Clin. Med"},{"issue":"11","key":"10.1016\/j.biopha.2024.116492_bib3","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1681\/ASN.2004090740","article-title":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients","volume":"16","author":"Chertow","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116492_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute kidney injury and chronic kidney disease as interconnected syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.116492_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.kint.2018.08.036","article-title":"Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure","volume":"95","author":"See","year":"2019","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.biopha.2024.116492_bib6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrneph.2015.3","article-title":"Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD","volume":"11","author":"Ferenbach","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"18","key":"10.1016\/j.biopha.2024.116492_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810880","article-title":"From AKI to CKD: Maladaptive repair and the underlying mechanisms","volume":"23","author":"Wang","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.116492_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41581-018-0103-6","article-title":"Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications","volume":"15","author":"Guo","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116492_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","article-title":"Histone recognition and large-scale structural analysis of the human bromodomain family","volume":"149","author":"Filippakopoulos","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.116492_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107479","article-title":"Make your best BET: the emerging role of BET inhibitor treatment in malignant tumors","volume":"208","author":"Bechter","year":"2020","journal-title":"Pharm. Ther."},{"issue":"390","key":"10.1016\/j.biopha.2024.116492_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5084","article-title":"BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure","volume":"9","author":"Duan","year":"2017","journal-title":"Sci. Transl. Med"},{"issue":"2","key":"10.1016\/j.biopha.2024.116492_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.imlet.2015.05.016","article-title":"Targeting bromodomain-containing protein 4 (BRD4) benefits rheumatoid arthritis","volume":"166","author":"Zhang","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.biopha.2024.116492_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.555591","article-title":"Inhibition of Brd4 by JQ1 promotes functional recovery from spinal cord injury by activating autophagy","volume":"14","author":"Li","year":"2020","journal-title":"Front Cell Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116492_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ph15020121","article-title":"Epigenetic Modulation of Gremlin-1\/NOTCH pathway in experimental crescentic immune-mediated glomerulonephritis","volume":"15","author":"Tejedor-Santamaria","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.biopha.2024.116492_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010486","article-title":"Type IV Collagen and SOX9 are molecular targets of BET inhibition in experimental glomerulosclerosis","volume":"24","author":"Morgado-Pascual","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116492_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.biochi.2019.07.012","article-title":"BRD4 contributes to high-glucose-induced podocyte injury by modulating Keap1\/Nrf2\/ARE signaling","volume":"165","author":"Zuo","year":"2019","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.biopha.2024.116492_bib17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1681\/ASN.2015080910","article-title":"Inhibition of bromodomain and extraterminal domain family proteins ameliorates experimental renal damage","volume":"28","author":"Suarez-Alvarez","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2024.116492_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114153","article-title":"Discovery of indol-6-yl-pyrrolo[2,3-c]pyridin-7-one derivatives as bromodomain-containing protein 4 (BRD4) inhibitors for the treatment of kidney fibrosis","volume":"231","author":"Tao","year":"2022","journal-title":"Eur. J. Med Chem."},{"issue":"2","key":"10.1016\/j.biopha.2024.116492_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111507","article-title":"Bromodomain-containing protein 4 contributes to renal fibrosis through the induction of epithelial-mesenchymal transition","volume":"383","author":"Wang","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2024.116492_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.redox.2016.12.031","article-title":"Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-\u03b2-mediated Nox4 expression","volume":"11","author":"Zhou","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2024.116492_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101195","article-title":"Inhibition of Brd4 alleviates renal ischemia\/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress","volume":"24","author":"Liu","year":"2019","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116492_bib22","doi-asserted-by":"crossref","first-page":"F469","DOI":"10.1152\/ajprenal.00527.2017","article-title":"Protective effect of the BET protein inhibitor JQ1 in cisplatin-induced nephrotoxicity","volume":"315","author":"Sun","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"7327","key":"10.1016\/j.biopha.2024.116492_bib23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2024.116492_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13578-018-0258-7","article-title":"+)-JQ1 attenuated LPS-induced microglial inflammation via MAPK\/NF\u03baB signaling","volume":"8","author":"Wang","year":"2018","journal-title":"Cell Biosci."},{"issue":"9","key":"10.1016\/j.biopha.2024.116492_bib25","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/s41416-021-01321-0","article-title":"Achieving clinical success with BET inhibitors as anti-cancer agents","volume":"124","author":"Shorstova","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2024.116492_bib26","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1084\/jem.20130376","article-title":"BET bromodomain inhibition suppresses TH17-mediated pathology","volume":"210","author":"Mele","year":"2013","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.116492_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/med.21730","article-title":"Inhibitors of bromodomain and extra-terminal proteins for treating multiple human diseases","volume":"41","author":"Kulikowski","year":"2021","journal-title":"Med Res Rev."},{"issue":"8","key":"10.1016\/j.biopha.2024.116492_bib28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41573-019-0030-7","article-title":"Bromodomains: a new target class for drug development","volume":"18","author":"Cochran","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2024.116492_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.212823","article-title":"Synthesis of a theranostic platform based on fibrous silica nanoparticles for the enhanced treatment of triple-negative breast cancer promoted by a combination of chemotherapeutic agents","volume":"137","author":"Ovejero-Paredes","year":"2022","journal-title":"Biomater. Adv."},{"issue":"29","key":"10.1016\/j.biopha.2024.116492_bib30","doi-asserted-by":"crossref","first-page":"12024","DOI":"10.1073\/pnas.1305538110","article-title":"Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury","volume":"110","author":"Linkermann","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2024.116492_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnology"},{"issue":"12","key":"10.1016\/j.biopha.2024.116492_bib32","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.drudis.2020.09.031","article-title":"Recent advances in targeted nanomedicine as promising antitumor therapeutics","volume":"25","author":"Hejmady","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.biopha.2024.116492_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biopha.2024.116492_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010131","article-title":"The application of nanoparticles in diagnosis and treatment of kidney diseases","volume":"23","author":"Paluszkiewicz","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116492_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/cancers12010091","article-title":"Nanoparticles loaded with the BET Inhibitor JQ1 Block the Growth of Triple Negative Breast Cancer Cells In Vitro and In Vivo","volume":"12","author":"Maggisano","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2024.116492_bib36","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/s41467-018-04315-4","article-title":"Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles","volume":"9","author":"Lam","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2024.116492_bib37","article-title":"Reversing T cell dysfunction to boost glioblastoma immunotherapy by paroxetine-mediated GRK2 inhibition and blockade of multiple checkpoints through biomimetic nanoparticles","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"2","key":"10.1016\/j.biopha.2024.116492_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2013the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control Release"},{"issue":"3","key":"10.1016\/j.biopha.2024.116492_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10173","article-title":"The effect of size, charge, and peptide ligand length on kidney targeting by small, organic nanoparticles","volume":"5","author":"Huang","year":"2020","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.biopha.2024.116492_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2021.04.016","article-title":"Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions","volume":"334","author":"Huang","year":"2021","journal-title":"J. Control Release"},{"issue":"8","key":"10.1016\/j.biopha.2024.116492_bib41","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1039\/C7BM00271H","article-title":"Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease","volume":"5","author":"Wang","year":"2017","journal-title":"Biomater. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2024.116492_bib42","doi-asserted-by":"crossref","first-page":"20160055","DOI":"10.1098\/rsfs.2016.0055","article-title":"Recent advances in the preparation and application of multifunctional iron oxide and liposome-based nanosystems for multimodal diagnosis and therapy","volume":"6","author":"Marciello","year":"2016","journal-title":"Interface Focus"},{"issue":"10","key":"10.1016\/j.biopha.2024.116492_bib43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41578-018-0038-3","article-title":"Transport and interactions of nanoparticles in the kidneys","volume":"3","author":"Du","year":"2018","journal-title":"Nat. Rev. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2024.116492_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mvr.2008.09.004","article-title":"Alteration of microvascular permeability in acute kidney injury","volume":"77","author":"Sutton","year":"2009","journal-title":"Micro Res."},{"issue":"4","key":"10.1016\/j.biopha.2024.116492_bib45","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/acs.bioconjchem.6b00057","article-title":"Renal targeting: peptide-based drug delivery to proximal tubule cells","volume":"27","author":"Wischnjow","year":"2016","journal-title":"Bioconj Chem."},{"issue":"4","key":"10.1016\/j.biopha.2024.116492_bib46","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","volume":"10","author":"Holt-Casper","year":"2015","journal-title":"Nano Today"},{"issue":"6","key":"10.1016\/j.biopha.2024.116492_bib47","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","article-title":"liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties","volume":"42","author":"Moghimi SM","year":"2023","journal-title":"Prog. Lipid Res"},{"key":"10.1016\/j.biopha.2024.116492_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110262","article-title":"Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers","volume":"107","author":"Lazaro-Carrillo","year":"2020","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"issue":"4","key":"10.1016\/j.biopha.2024.116492_bib49","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cell.2012.06.045","article-title":"Small-molecule inhibition of BRDT for male contraception","volume":"150","author":"Matzuk","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2024.116492_bib50","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/cpt.2099","article-title":"Toward consensus on correct interpretation of protein binding in plasma and other biological matrices for COVID-19 therapeutic development","volume":"110","author":"Boffito","year":"2021","journal-title":"Clin. Pharm. Ther."},{"issue":"24","key":"10.1016\/j.biopha.2024.116492_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249620","article-title":"Inhibition of BRD4 reduces neutrophil activation and adhesion to the vascular endothelium following ischemia reperfusion injury","volume":"21","author":"Reid","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.116492_bib52","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/MCB.01365-08","article-title":"Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA","volume":"29","author":"Huang","year":"2009","journal-title":"Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116492_bib53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri2215","article-title":"How dying cells alert the immune system to danger","volume":"8","author":"Kono","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2024.116492_bib54","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1172\/JCI45161","article-title":"Cellular pathophysiology of ischemic acute kidney injury","volume":"121","author":"Bonventre","year":"2011","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.biopha.2024.116492_bib55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/nep.12941","article-title":"Phenotype and influx kinetics of leukocytes and inflammatory cytokine production in kidney ischemia\/reperfusion injury","volume":"23","author":"Williams","year":"2018","journal-title":"Nephrol. (Carlton)"},{"issue":"12","key":"10.1016\/j.biopha.2024.116492_bib56","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/ki.2008.500","article-title":"The chemokine receptors CCR2 and CX3CR1 mediate monocyte\/macrophage trafficking in kidney ischemia-reperfusion injury","volume":"74","author":"Li","year":"2008","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.biopha.2024.116492_bib57","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1681\/ASN.2012090890","article-title":"Slit2 prevents neutrophil recruitment and renal ischemia-reperfusion injury","volume":"24","author":"Chaturvedi","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116492_bib58","doi-asserted-by":"crossref","first-page":"F1501","DOI":"10.1152\/ajprenal.00195.2018","article-title":"Immune cells and inflammation in AKI to CKD progression","volume":"315","author":"Sato","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116492_bib59","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1681\/ASN.2017121283","article-title":"Interleukin-1\u03b2 Activates a MYC-dependent metabolic switch in kidney stromal cells necessary for progressive tubulointerstitial fibrosis","volume":"29","author":"Lemos","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2024.116492_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.817974","article-title":"Role of nanotechnology and their perspectives in the treatment of kidney diseases","volume":"12","author":"Merlin","year":"2022","journal-title":"Front Genet"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:20:01Z","timestamp":1782343201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224003767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":60,"alternative-id":["S0753332224003767"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116492","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BET inhibitor nanotherapy halts kidney damage and reduces chronic kidney disease progression after ischemia-reperfusion injury","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116492"}}